Table of Contents
Executive Summary
Industry Introduction, including Taxonomy and Market Definition
Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
Global Market Demand Analysis 2020 to 2024 and Forecast 2025 to 2035, including Historical Analysis and Future Projections
Pricing Analysis
Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035
- Type
- Drug Class
- Distribution Channel
By Type
- Hemophilia A
- Hemophilia B
- Other Types
By Drug Class
- Plasma-derived Coagulation Factor Concentrates
- Recombination Coagulation Factor Concentrates
- Fibrin Sealants
- Other Drug Classes
By Distribution Channel
- Hospital Pharmacies
- Drug Stores and Retail Pharmacies
- Online Pharmacies
By Region
Sales Forecast to 2035 by Type, Drug Class, and Distribution Channel for 30 Countries
Competitive Assessment, Company Share Analysis by Key Players, and Competition Dashboard
Company Profile
- Bayer AG
- CSL Behring
- Grifols International SA
- Novo Nordisk A/S
- Octapharma AG
- Pfizer, Inc.
- Other Prominent Players
Who worked on this report
Preview the report firsthand - request a free sample
Free SampleGet the brochure for pricing and purchase details
Download PDF